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Highlights 
 Targeting PEDV spike protein domains to Langerin-expressing dendritic cells through a 
single chain antibody 
 Transdermal Langerin-targeting of PEDV S antigen significantly enhanced CD4 T cell 
immunity 
 Systemic Langerin-targeting of PEDV S antigen significantly augmented serum IgG and 
IgA responses  
 
 
Abstract 
 Porcine epidemic diarrhea virus (PEDV) first emerged in the United States in 2013 
causing high mortality and morbidity in neonatal piglets with immense economic losses to the 
swine industry. PEDV is an alpha-coronavirus replicating primarily in porcine intestinal cells. 
PEDV vaccines are available in Asia and Europe, and conditionally-licensed vaccines recently 
became available in the United States but the efficacies of these vaccines in eliminating PEDV 
from swine populations are questionable. In this study, the immunogenicity of a subunit vaccine 
based on the spike protein of PEDV, which was directly targeted to porcine dendritic cells (DCs) 
expressing Langerin, was assessed. The PEDV S antigen was delivered to the dendritic cells 
through a single-chain antibody specific to Langerin and the targeted cells were stimulated with 
cholera toxin adjuvant. This approach, known as “dendritic cell targeting,” greatly improved 
PEDV S antigen-specific T cell interferon-γ responses in the CD4posCD8pos T cell compartment 
in pigs as early as 7 days upon transdermal administration. When the vaccine protein was 
targeted to Langerinpos DCs systemically through intramuscular vaccination, it induced higher 
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serum IgG and IgA responses in pigs, though these responses require a booster dose, and the 
magnitude of T cell responses were lower as compared to transdermal vaccination. We conclude 
that PEDV spike protein domains targeting Langerin-expressing dendritic cells significantly 
increased CD4 T cell immune responses in pigs. The results indicate that the immunogenicity of 
protein subunit vaccines can be greatly enhanced by direct targeting of the vaccine antigens to 
desirable dendritic cell subsets in pigs. 
 
 
Keywords: porcine epidemic diarrhea virus (PEDV); porcine Langerin; dendritic cell targeting; 
T cell immunity; subunit vaccine 
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1. Introduction  
Porcine epidemic diarrhea (PED) is a transboundary disease of pigs that is endemic 
primarily in Asia and Europe (Song et al., 2015). In 2013, the disease emerged for the first time 
in the United States and quickly spread to more than 30 states (Stevenson et al., 2013). The 
disease mainly affects neonatal piglets often presented with watery diarrhea, vomiting, and 90-
95% mortality in naïve populations (Stevenson et al., 2013) causing immense economic losses to 
the swine industries (Schulz and Tonsor, 2015). The causative agent of the disease is porcine 
epidemic diarrhea virus (PEDV), an alpha-coronavirus in the family Coronaviridae (Chasey and 
Cartwright, 1978; Tobler et al., 1993). PEDV encodes four structural proteins: Spike (S), 
Envelope (E), Membrane (M) and Nucleocapsid (N) (Brian and Baric, 2005). PEDV S protein is 
a type I transmembrane protein. The extracellular portion of S protein contains major antigenic 
determinants, and is made up of three domains, N-terminal domain (NTD), S1 domain and S2 
domain.  The S1 and S2 domains contain potential virus neutralizing epitopes (Huang et al., 
2013; Song and Park, 2012). A recombinant, spike-based (NTD-S1) vaccine induces virus-
neutralizing antibody responses in pregnant sows and protected their offspring from mortality 
(Oh et al., 2014). However, the cellular immune responses of this protein subunit vaccine have 
not been determined. Recent studies showed that PEDV infection or vaccination enhanced the 
antigen presenting capabilities of porcine DCs in vitro and in vivo which subsequently stimulated 
T cell proliferation efficiently (Gao et al., 2015; Gao et al., 2016).  
In mouse and monkey models, Human immunodeficiency virus gag antigens were 
targeted to specific dendritic cell (DC) subsets expressing c-type lectin receptors (CLRs) in order 
to generate effective cellular immune responses even at low antigenic doses (Trumpfheller et al., 
2012). More recently, we successfully targeted porcine reproductive and respiratory syndrome 
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virus (PRRSV) antigen to a pig DC subset expressing DC-SIGN that effectively primed CD4 T 
cells in pigs at a low antigenic dose (Subramaniam et al., 2014). However, the effects of antigen 
targeting to additional porcine CLRs are entirely unknown.  
Langerin is a CLR expressed in DC subsets residing in the epidermis, dermis, spleen, 
peripheral lymph nodes, and peripheral tissues (Idoyaga et al., 2008; Maisonnasse et al., 2015; 
Marquet et al., 2014). Porcine Langerin is expressed in epidermal Langerhans cells (LCs), in a 
subset of dermal CD163low DCs and in type 2 conventional DCs in lung (Maisonnasse et al., 
2015; Marquet et al., 2014). Mouse LCs and Langerinpos DCs targeted with Ovalbumin antigen 
presented both MHC-I and MHC-II products to stimulate Th1 and cytotoxic T lymphocytes, 
respectively (Idoyaga et al., 2008). Langerinpos CD8αneg DCs were differentiated from bone 
marrow DC precursors in the skin in response to transcutaneous immunization of mice with 
tetanus toxoid and cholera toxin, which then accumulated in mesenteric lymph nodes and 
efficiently induced gut secretory IgA responses (Chang et al., 2008).  
The protection against PEDV infection in piglets is mainly provided by lactogenic 
immunity through colostrum and milk of sows previously exposed to low pathogenic or live-
attenuated virus (Goede et al., 2015; Oh et al., 2014; Song and Park, 2012). Intraperitoneal 
administration of PEDV-specific antibodies obtained from sera of PEDV-infected sows reduced 
disease severity and increased survival of piglets upon virus challenge (K.Poonsuk, 2015). Prior 
exposure of 11 day-old piglets with PEDV showed reduced morbidity upon re-challenge with 
virus three weeks later (de Arriba et al., 2002). The reduced morbidity strongly correlated with 
the frequencies of PEDV-specific antibody-secreting cells in intestinal tissues as well as with 
serum PEDV-specific antibody levels at the day of challenge (de Arriba et al., 2002). On the 
other hand, PEDV induces significantly higher CD4 T cell responses but not CD8 T cell 
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responses in ileal tissues of suckling piglets as compared to the weaned piglets. (Annamalai et 
al., 2015)  However, the role of these CD4 T cell immune responses induced by PEDV to  
protection in pigs remains unknown.  
In this study, we evaluated the immunogenicity of PEDV spike protein domains NTD-S1 
targeted directly to Langerin-expressing DC subsets in the skin and in systemic sites. The cholera 
toxin was co-administered as adjuvant, which acts on mouse CD11bpos DCs through stimulating 
the alpha-subunit of stimulatory heterotrimeric G protein (Gsα) in order to promote Th1 and Th2 
responses (Mattsson et al., 2015). Pigs were vaccinated through transdermal or intramuscular 
routes during priming followed by intramuscular route during boosting in order to evaluate the 
effects of different vaccination routes on priming of cellular and humoral immune responses due 
to the Langerin targeting of PEDV S antigen.   
2. Materials and Methods  
2.1. Cell lines, virus stock and antibodies 
       Vero cells and Chinese Hamster Ovary (CHO-K1) cells (ATCC) were maintained in Eagle 
minimum essential medium (MEM) or Dulbecco’s modified eagle medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS). Human embryonic kidney (293T) cells were 
maintained in Pro293aCDM (Lonza) supplemented with 4% FBS, and after transient 
transfections, they were maintained in Iscove’s modified Dulbecco’s Medium (IMDM) 
supplemented with 2% ultra-low IgG FBS (Gibco). PEDV-CO/13 strain (Marthaler et al., 2013) 
was propagated in Vero cells with MEM maintenance medium supplemented with 0.02% yeast 
extract, 0.3% tryptose phosphate broth and 2 μg/mL trypsin. The antibodies used for flow 
cytometry analysis were described previously (Subramaniam et al., 2014).  
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2.2. Production of PEDV vaccine antigens  
Mouse monoclonal antibodies specific to porcine Langerin were generated as described 
previously (Subramaniam et al., 2014) and evaluated using Pierce Rapid Antibody Isotyping kit. 
The variable (V) domains of mAb 3B3 (isotype G1, κ) were PCR-amplified and genetically 
linked through a flexible linker to make a single-chain-variable-fragment (scFv). The 3B3scFv 
was subsequently cloned in pFUSE-pIgG2Fc2 (Subramaniam et al., 2014) and pFUSE-hIgG2Fc2 
(Invivogen) to make porcine and human Fc fusion antibodies, respectively. The S protein 
domains (amino acids 21-737) of the PEDV MN strain (Huang et al., 2013) (GenBank accession 
no. KF468752.1) was genetically combined with the carboxy terminus of porcine Fc or 3B3scFv-
porcine Fc in pFUSE vectors. Recombinant vaccine antigens were produced by large-scale 
transient transfections of 293T cells and purified using protein A agarose beads as described 
previously (Subramaniam et al., 2014).  
2.3. Experimental design of the pig immunogenicity study  
 A total of 31 four-week-old PEDV-negative piglets were divided into four treatment 
groups: Adjuvant control (group 1), non-targeted (group 2), transdermal DC-targeted (group 3), 
and intramuscular DC-targeted (group 4) (Table 1). On day 0, pigs were administered with 200 
μg recombinant antigen mixed with 50 μg cholera toxin (CT) transdermally in groups 2 and 3 but 
intramuscularly in group 4, while pigs in group 1 received 50 μg CT only through transdermal 
route. The transdermal vaccination was performed as previously described (Subramaniam et al., 
2014) using a needle less injector that delivered the antigens in skin using 65 psi compressed 
CO2. On day 28, pigs received a second dose of antigen-adjuvant mixtures (groups 2, 3, and 4) or 
adjuvant only (group 1) through the intramuscular route. Blood and fecal samples were collected 
at weekly time points (Fig S1).  
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2.4. Intracellular IFN-γ staining and flow cytometry 
 Antigen-specific T cell responses were analyzed in T cell populations by in vitro antigen 
stimulation of mononuclear cells isolated from peripheral blood followed by intracellular 
staining of IFN-γ and subsequent flow cytometry analysis (Subramaniam et al., 2014). 
2.5. Immunofluorescence assay  
 CHO-K1 cells were transfected with plasmids expressing porcine Langerin or CD137 
(irrelevant gene control) using Lipofectamine LTX (Thermo Fisher Scientific). After 48 h, cells 
were fixed with 3.2 % paraformaldehyde, permeabilized with Triton X-100, and blocked with 
3% bovine serum albumin (BSA). Cells were subsequently stained with Langerin-specific 
antibodies (1μg: 100μL) in blocking buffer followed by incubation with fluorochrome-
conjugated secondary antibodies. DAPI (4', 6-diamidino-2-phenylindole) was used to stain the 
cell nucleus, and cells were imaged in Nikon Eclipse TE 300 fluorescence microscope. 
2.6. Serum virus neutralization test  
Vero cells were seeded in 96 well cell culture plates one day prior to testing. Pig serum 
samples were heat-inactivated at 56°C for 30 min and serially diluted two-fold with MEM. 
PEDV CO/13 strain was prepared at a concentration of 2,000 TCID50/mL MEM and added to 
diluted sera at 1:1 ratio. We chose PEDV CO/13 strain for serum neutralizing test considering 
the fact that there are only two amino acid differences between S protein of PEDV-MN (Huang 
et al., 2013) and PEDV-CO/13 (Marthaler et al., 2013). These amino acid differences are located 
in NTD-S1 domains outside the neutralizing epitope containing region of PEDV S protein 
(Chang et al., 2002; Sun et al., 2008). The virus-serum mixtures were then incubated at 37°C for 
1 h, and then transferred to Vero cell monolayers on 96 well cell culture plates (100 μL per well) 
which had been washed with MEM once. Cells were incubated at 37°C for 1 h and subsequently 
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washed with MEM three times. Maintenance medium containing trypsin (2μg/mL) was added to 
the cells and further incubated at 37°C for 5 days. Serum virus neutralization (SVN) titers were 
calculated as the reciprocals of the highest serum dilution resulting in complete inhibition of 
PEDV-induced cytopathic effect. Geometric means were calculated for triplicate as well as for 
groups. 
2.7. ELISA 
ELISA plates (96 well) were coated with PEDV NTD-S1 antigen (2 μg/mL) overnight at 
4° C. Plates were washed and blocked with 150μL 5% non-fat milk for 2 h at 37° C. Diluted sera 
(1:400) and undiluted fecal extracts were applied in duplicate and incubated at 37°C for 1 h. Pig 
fecal extracts were prepared as previously described (Cordes et al., 2012). Wells were 
extensively washed and incubated with 100 μL secondary conjugates (Horse Radish Peroxidase 
(HRP)-conjugated anti-pig IgG (Santa Cruz Biotech) or anti-pig IgA (Bethyl) at 37°C for 1 h. 
Wells were extensively washed and incubated with 100 μL HRP substrate (KPL) for 5 min, and 
the reaction was stopped with 1N HCl. Absorbance was measured at 450 nm in microplate reader 
(Tecon or Promega Glomax). Sample-to-positive (S/P) ratio was calculated as: (sample mean – 
negative control mean) / (positive control mean – negative control mean) where “mean” is the 
average optical density (OD) at 450 nm of the duplicate samples. 
2.8. Thiocyanate elution ELISA 
To measure the relative affinities of Langerin mAbs, a thiocyanate elution based ELISA 
was carried out with purified mAbs and Langerin antigens as described elsewhere (Macdonald et 
al., 1988).  
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2.9. Statistical analysis 
 The significance in the difference between means of two treatment groups was 
determined by unpaired student ‘t’ test assuming Gaussian distribution of variables. GraphPad 
Prism version 6 and Microsoft Excel programs were used to perform statistical analyses. A p 
value of less than 0.05 was considered statistically significant when the sample size n was ≥ 7. 
 
3. Results  
3.1. Characterization of a recombinant single chain antibody specific to porcine Langerin 
We generated mouse mAbs (clones 3B3 and 5G7) specific to porcine Langerin by 
following conventional hybridoma technology. In thiocyanate elution ELISA analysis, the 
relative affinity of the 3B3 mAb (affinity index > 3.5) was found to be much higher than that of 
the 5G7 mAb (affinity index ≈ 0.4) (Fig 1A). Since higher affinity antibodies are desired for 
“dendritic cell targeting” (Cheong et al., 2010), the 3B3 mAb was chosen for further analysis. 
The 3B3 mAb was shown to specifically stain the native porcine Langerin but not an irrelevant 
porcine cellular receptor; both were expressed exogenously on CHO-K1 cells (Fig 1B). The 
recombinant 3B3 single chain antibody, which is a human Fc fused with 3B3scFv, also 
specifically stained the over-expressed porcine Langerin on CHO-K1 cells comparable with that 
of a positive control antibody 929F3.01 (Fig 1B). The Langerin-targeting PEDV S antigen, 
which is porcine Fc fused with 3B3scFv at the amino terminus and with PEDV S antigen at the 
carboxy terminus (3B3scFv-pFc-PEDVsAg) (Fig 1C), was detected as an approximately 210 
KDa protein in SDS-PAGE analysis of transiently-transfected 293T cell lysates (Fig 1D). The 
porcine Fc fused with the PEDV NTD-S1 only (pFc-PEDVsAg) served as non-targeting antigen 
and identified as an approximately 180 KDa protein in the SDS-PAGE analysis (Fig 1C and 
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1D). In short, the recombinant 3B3 single chain antibody specifically binds porcine Langerin 
which can be produced as a fusion protein with PEDV S domains. 
3.2. T cell immune responses against Langerin-targeted PEDV spike protein domains in 
pigs 
 Subsequently, we evaluated whether Langerin-targeting of PEDV NTD-S1 enhanced the 
vaccine immunogenicity in pigs. First, we measured T cell immune responses against DC-
targeted PEDV NTD-S1s in pigs. The peripheral blood mononuclear cells were isolated, 
stimulated in vitro with the recombinant NTD-S1 antigen, and stained for intracellular IFN-γ. 
Flow cytometry analyses showed that the CD4posCD8pos T cell subset was the only subset 
showing increased mean frequencies of IFN-γ producing cells in response to PEDV NTD-S1 
(Fig 2). As early as 7 days after the prime vaccination in pigs, the antigen-specific CD4 T cell 
frequencies in the transdermal DC-targeted group were significantly higher (0.969±0.201, 
p≤0.025) than those in the non-targeted group (0.395±0.158) and in the intramuscular DC-
targeted group (0.483±0.067) (Fig 2B). The CD4 T cell priming sustained in a proportion of pigs 
(2/8) in the transdermal DC-targeted group (p=0.027) until 28 days after prime vaccination (Fig 
2C). At day 7 after booster vaccination, IFN-γ-specific CD4 T cell responses increased 
significantly in the transdermal DC-targeted group (0.391±0.107, p=0.016) as compared to the 
non-targeted group (0.108±0.052) (Fig 2D). Our results indicate that transdermal delivery of 
Langerin-targeted PEDV S antigen significantly increased cellular responses in the 
CD4posCD8pos T cell compartment in pigs. 
3.3. Effect of Langerin targeting of PEDV S antigen on humoral responses in pigs  
 We evaluated antibody responses against PEDV S antigen targeted to Langerinpos DCs. 
The first vaccine dose induced detectable levels of antigen-specific serum IgG but not IgA 
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starting at 21 days after vaccination in all vaccinated groups but not in the control group (Fig 3). 
However, serum IgG levels specific to PEDV NTD-S1 increased considerably upon the second 
vaccine dose (Fig 3A). Particularly, at day 7 after boosting, the mean IgG S/P ratio was 
significantly higher in the intramuscular DC-targeted group (1.372±0.039, p=0.037) than in the 
transdermal DC-targeted group (1.230±0.059) (Fig 3A). The higher serum IgG levels in the 
intramuscular DC-targeted group sustained until 14 days after boosting (mean S/P ratio: 
1.337±0.052, p=0.005) as compared to transdermal DC-targeted group (mean S/P ratio: 
1.048±0.076) at the same time point (Fig 3A). In contrast, substantial IgA levels were detected 
only from day 7 after the booster vaccination in all vaccinated groups but not in the control 
group. The mean IgA S/P ratio was much higher in the intramuscular DC-targeted group 
(0.346±0.118, p=0.001) than transdermal DC-targeted group (0.053±0.007) (Fig 3B). However, 
there was no significant difference in both IgG and IgA antibody levels between the non-targeted 
and transdermal DC-targeted groups (Fig 3A, 3B). Our data suggest that pigs primed 
intramuscularly with DC-targeted PEDV NTD-S1 showed significantly higher IgG and IgA 
responses as compared to those primed through the transdermal route though these responses 
require an intramuscular booster vaccination. 
3.4. Serum virus neutralizing antibody responses  
 We tested whether the serum antibodies induced against Langerin-targeted PEDV S 
antigen can neutralize the virus under in vitro conditions. The virus neutralizing antibodies were 
measured in serum samples by in vitro serum virus neutralizing test with PEDV CO/13 strain. 
Strong neutralizing antibody (Nab) responses were detected in all groups vaccinated with PEDV 
NTD-S1 at 7 days post-boosting, without significant differences, while the adjuvant control 
group did not show serum neutralizing activities (Fig 5A). The mean PEDV-specific Nab titers 
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ranged between 32 and 64 in the groups vaccinated with PEDV NTD-S1 irrespective of DC 
targeting (Fig 5A). There was a strong positive correlation between PEDV-specific virus 
neutralizing antibody and IgG levels in serum (r = 0.88, p < 0.0001) but there was no evidence of 
correlation between virus neutralizing antibody and IgA levels in serum (r = 0.34, p = 0.062) 
(Fig 5B, 5C). These results demonstrate convincingly that PEDV spike NTD-S1 induced a 
robust serum virus neutralizing antibody response in pigs, and the levels were not influenced by 
Langerin targeting of the antigen. 
3.5. Gut IgA responses in vaccinated pigs 
 Finally, we examined the secretory levels of IgAs in pig feces at 35 days post-prime 
vaccination when the serum IgA responses were maximal in individual vaccination groups. 
There was no significant level of fecal IgAs in the intramuscular and the transdermal Langerin-
targeted groups despite significant higher serum IgA levels were observed after booster 
vaccination (Fig 4 and 3B). Similarly, no significant numbers of PEDV NTD-S1-specific IgA 
secreting cells were detected in ileal tissues of pigs in Langerin-targeted groups at necropsy (data 
not shown). These results imply that Langerin-targeting of PEDV NTD-S1 did not significantly 
induce secretory IgA responses in the gastro-intestinal tract of pigs regardless of the vaccination 
route. 
 
4. Discussion  
The ongoing PEDV outbreaks in the United States have devastated the swine industry 
and currently there is no fully-licensed PEDV vaccine in the United States. Modified live PEDV 
vaccines are available in Asia, but the efficacy of these vaccines is questionable as they do not 
completely prevent virus shedding and outbreaks of PED continue in Asia (de Arriba et al., 
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2002; Oh et al., 2014). Therefore, more effective vaccines are needed to eradicate PEDV 
altogether from neonates, growing and adult pigs particularly in breeding herds. In this study, we 
developed a novel spike-based PEDV subunit vaccine candidate that was directly targeted to pig 
Langerin-expressing dendritic cells through a single chain antibody. This vaccine candidate 
enhanced the cellular immune responses, particularly in the CD4pos CD8pos T cell compartment if 
the vaccine was injected transdermally. This is important since traditional subunit protein-based 
vaccines typically do not induce strong cell-mediated immune responses. However, enhanced 
antibody predominantly IgG responses but reduced cellular immune responses were observed if 
the PEDV NTD-S1 was targeted to Langerinpos DCs in systemic sites in pigs. Our study shows 
that the “dendritic cell targeting” approaches could be incorporated into PEDV subunit vaccine 
developments to improve the efficacy of protein-based vaccines by modulating the cellular and 
humoral immune responses against PEDV. 
Antibodies binding to Langerin on DCs are rapidly internalized and co-localized within 
intracellular antigen presenting compartments in those cells (Nfon et al., 2008; Valladeau et al., 
2000).  The strong affinity and high specificity of the mAb 3B3 toward porcine Langerin is ideal 
for inducing rapid internalization of Langerin molecules in porcine DCs. The 3B3scFv-based 
single chain recombinant antibody showed a binding capacity similar to the mAb 3B3 which 
might mean an added advantage of monocistronic expression. 
 Consistent with previous studies in mouse models (Idoyaga et al., 2008; Idoyaga et al., 
2011), our study demonstrate that Langerin targeting of PEDV NTD-S1 in skin enhanced T cell 
immune responses, though restricted only to the CD8posCD4pos T cell compartment that provides 
both cytolytic and helper immune responses to fight viral infections in pigs (C. Chung, 2015; 
Gerner et al., 2009) by swine leukocyte antigen (SLA) class II restricted manner (Gerner et al., 
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2009). The results of our study also indicate that the memory immune responses are indeed 
developed effectively in pigs due to Langerin-targeting of PEDV antigen as demonstrated by the 
increased frequencies of antigen-specific CD4pos CD8pos T cells which are considered as the 
effector memory T cells in pigs (Gerner et al., 2009). The overall magnitude of CD4 T cell 
responses against Langerin-targeted PEDV NTD-S1 was comparatively higher in pigs vaccinated 
by the transdermal route, when compared to the intramuscular route, which is possibly mediated 
by either pig Langerinpos dermal DCs or LCs or both (Marquet et al., 2014; Romani et al., 2012). 
This is consistent with reports that mouse Langerinpos dermal DCs are capable of inducing strong 
T cell immune responses in skin draining lymph nodes (Wang et al., 2008), while human LCs are 
capable of engulfing measles virus particles through Langerin molecules to present viral antigens 
to CD4 but not CD8 T cells  (van der Vlist et al., 2011).   
Interestingly, in our study, the antibody responses against Langerin-targeted antigen were 
influenced by the route of antigen delivery during priming. Our data suggest that IgG responses 
were slightly stronger against intramuscular administered targeted PEDV NTD-S1 when 
compared to transdermal administered antigen, however both groups showed this difference only 
after intramuscular boosting, which is quite contrary to the observed T cell responses after 
priming. This difference may be explained by the fact that pig Langerinpos DCs in systemic sites 
are a fraction of CD11cpos DCs which are classified as conventional type 2 DCs biased toward 
inducing Th2 responses (Bigley et al., 2015; Maisonnasse et al., 2015). Therefore, it is warranted 
to examine Th2 immune responses against porcine Langerin-targeted antigens in systemic sites 
in future studies. In addition, when compared to the transdermal vaccination, the intramuscular 
vaccination route made the antigen more readily accessible in mucosal lymphoid tissues 
producing significant IgA responses against PEDV NTD-S1. However, the significant 
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differences in antibody responses between the transdermal and the intramuscular vaccination 
were not recognizable at the serum neutralizing antibody levels at one week after booster 
vaccination.  
Consistent with the previous study (Paudel et al., 2014), there was a positive and strong 
correlation between serum IgG levels specific to PEDV NTD-S1 and the serum virus 
neutralizing antibody levels further confirming that the spike protein is a determinant of PEDV 
neutralization (Song and Park, 2012). Unlike the murine immune system (Chang et al., 2008), 
there was no evidence of cross-talk between porcine skin and gut immune system through 
Langerinpos DCs in the presence of cholera toxin, as we did not observe significant gut IgA 
responses against the PEDV NTD-S1 delivered transdermally.  
The efficacies of DC-targeted vaccines have been extensively investigated in mouse and 
primate models, and have successfully advanced up to phase III clinical trials in humans as 
potential cancer therapeutic vaccines (Apostolopoulos et al., 2014). In this study, we demonstrate 
the immunogenicity of spike-based protein vaccines against PEDV can be manipulated toward 
better cellular immune responses if the vaccine antigen is targeted to Langerinpos DCs in the pig 
skin. However, when the PEDV NTD-S1 is targeted to Langerinpos DCs in pig systemic sites, 
enhanced humoral immune responses can be observed, however these responses require a 
booster dose. The protective efficacy of these enhanced immune responses against PEDV need to 
be investigated in the future specifically in the pregnant gilt/sow vaccination - piglet challenge 
model. 
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Figure legends 
Figure 1. Characterization of porcine Langerin-specific antibodies. (A) Relative affinities of 
mouse monoclonal antibodies (mAb) toward Langerin as measured by thiocyanate elution 
ELISA. The affinity index (‘a’) is the measure of ammonium thiocyanate molar concentration 
that produced 50% decrease in the initial absorbance corresponding to the y-axis value 1.7 
(dotted line). (B) Immunofluorescence analysis. CHO-K1 cells were transfected with plasmids 
expressing porcine Langerin or an irrelevant cellular receptor. After 48 h, cells were fixed, 
permeabilized and stained with indicated antibodies followed by corresponding fluorochrome-
conjugated secondary antibodies. DAPI blue staining indicated the cell nucleus. 929.F3.01 is an 
anti-human Langerin rat mAb known to cross-react with porcine Langerin. (C) Schematic 
illustration of vaccine antigen constructs. pFc-PEDVsAg and 3B3scFv-pFc-PEDVsAg are the 
non-targeting and Langerin-targeting PEDV spike-based vaccine antigens. “IL-2 ss” is the signal 
sequence derived from human IL-2 gene. VH and VL represent the variable domains of heavy and 
light chains of the 3B3 mAb. NTD-S1 represents n-terminal domain together with the S1 domain 
of the PEDV spike protein. (D) SDS-PAGE analysis. Vaccine antigens were prepared from the 
large scale 293T transient transfections and resolved in 4 -20 % SDS-PAGE followed by 
Coomassie blue staining. Lane 1: pFc-PEDVsAg; and Lane 2: 3B3scFv-pFc-PEDVsAg. The 
molecular sizes were determined by protein ladder in a separate well. 
 
Figure 2. T cell immune responses specific to Langerin-targeted PEDV vaccine antigen in 
pigs. (A-D) Flow cytometry analysis. Peripheral blood mononuclear cells were collected from 
vaccinated pigs at indicated timepoints, stimulated with PEDV NTD-S1 in vitro, stained for 
surface T cell receptors and intracellular IFN-γ. Data presented herein is for CD8posCD4pos T cell 
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compartment only as the percentage of CD3 gated T cell population. The frequencies of antigen-
specific T cells were calculated by subtracting the values of unstimulated cells from that of 
stimulated cells. (t/d), transdermal; (i/m), intramuscular. Data on the y-axis represent arithmetic 
mean of antigen-specific T frequencies ± standard error of mean, n ≥ 7. (*p < 0.05; **p < 0.01). 
 
Figure 3. Serum antibody responses specific to a Langerin-targeted PEDV vaccine antigen 
in pigs. (A) IgG and (B) IgA ELISA analyses. Microplates were coated with PEDV NTD-S1 
followed by blocking with non-fat milk. Diluted serum samples were incubated with coated 
antigen, and after several washings, the bound antibodies were detected with enzyme-conjugated 
secondary conjugates either anti-porcine IgG (A) or anti-porcine IgA (B) together with 
corresponding substrate. . The sample-to-positive (S/P) ratios were calculated as described in the 
methods section. Serum samples from PEDV negative pigs served as negative control while 
those collected from PEDV-infected pigs at 44 days post-infection served as positive control. 
Each sample was measured in duplicate. Data on the y-axis represent the arithmetic mean of S/P 
ratio values ± standard error of mean, n ≥ 7. (*p < 0.05; **p < 0.01). 
 
Figure 4. Serum virus neutralizing antibody responses specific to Langerin-targeted PEDV 
vaccine antigen in pigs. (A) Serum virus neutralization (SN) test on Vero cells. Heat-inactivated 
serum samples were mixed with PEDV CO/13 strain and incubated to allow for virus 
neutralization. Virus-serum mixtures were laid on Vero cell monolayer and incubated to allow 
for virus binding. Cells were washed three times with plain culture medium and incubated with 
serum-free maintenance medium containing trypsin for 5 days. Each sample was tested in 
triplicate and the SN titer was calculated as the geometric mean (GM) of titer values of each 
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sample. Data on the y-axis represent the geometric mean of SN titers ± standard error of mean, n 
≥ 7 (n. s. non-significant).  (B and C) Correlation analysis of serum neutralizing antibodies with 
serum IgG (B) or serum IgA (C) levels at 35 days post-prime vaccination. The Pearson 
correlation co-efficient (r) was calculated assuming Gaussian distribution of variables. A ‘p’ 
value of less than 0.05 was considered significant to consider for a true correlation (n = 30).  
 
Figure 5. IgA levels in feces of pigs at 35 days post-vaccination. Fecal samples were freeze-
dried and resuspended in extraction buffer (PBS with Tween-20 and protease inhibitors). Fecal 
extracts were clarified by centrifugation and the supernatants were collected to measure fecal 
IgAs. The undiluted fecal extracts were incubated with PEDV NTD-S1 antigen coated on 96 
well plates. After several washes, the bound antibodies were detected with horseradish 
peroxidase (HRP)-conjugated anti-porcine IgA secondary antibody followed by HRP substrate 
incubation. The enzyme reaction was stopped with HCl and the absorbance was measured at 450 
nm in a microplate reader. Each sample was measured in duplicate. Data on the y-axis represent 
the arithmetic mean of the optical density at 450 nm ± standard error of mean, n ≥ 7. 
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Table 1. Experimental design for the immunogenicity study in pigs of Langerin-targeted PEDV vaccine 
 
No. Treatment groups Antigen 
dose 
Adjuvant 
dose 
Vaccine 
Volume 
Prime route 
(single site) 
Booster 
route 
(single site) 
No. of 
pigs 
1 Adjuvant Control - 50μg 250μL Transdermal Intramuscular 8 
2 Non-targeted PEDVsAg 200μg 50μg 250μL Transdermal Intramuscular 8 
3 Langerin-targeted PEDVsAg 200μg 50μg 250μL Transdermal Intramuscular 8 
4 Langerin-targeted PEDVsAg 200μg 50μg 250μL Intramuscular Intramuscular 7 
 
 
